Abstract
Recent studies have added to our knowledge of the epidemiology of psoriatic arthritis (PsA) across various populations. Absence of a standard case definition and the relative rarity of PsA may have contributed to the paucity of available data to date. Reported prevalence estimates appear to vary more than incidence estimates. Prevalence estimates may vary as a result of differences in genetic factors, exposure to environmental factors, and study methods. Although prevalence data among different subgroups and extrapolation from clinical and laboratory data allow some inferences about the role of various potential risk factors for PsA, only one study has investigated them specifically. Overall, quality of life in PsA appears similar to that in rheumatoid arthritis, whereas available data on the mortality impact of PsA are conflicting, preventing a unified conclusion. This review summarizes recent data on PsA epidemiology.
Similar content being viewed by others
References and Recommended Reading
Mease P: Psoriatic arthritis update. Bull NYU Hosp Jt Dis 2006, 64:25–31.
Kruithof E, Baeten D, De Rycke L, et al.: Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005, 7:R569–580.
Gladman DD, Antoni C, Mease P, et al.: Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005, 64(Suppl 2):ii14–17.
Henseler T: The genetics of psoriasis. J Am Acad Dermatol 1997, 37:S1–11.
Naldi L: Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004, 3:121–128.
Gelfand JM, Stern RS, Nijsten T, et al.: The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005, 52:23–26.
Taylor W, Gladman D, Helliwell P, et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665–2673.
Alenius GM, Stenberg B, Stenlund H, et al.: Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002, 29:2577–2582.
Harrison BJ, Silman AJ, Barrett EM, et al.: Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol 1997, 24:1744–1749.
Lomholt G: Psoriasis: Prevalence, Spontaneous Course and Genetics: a Census Study on the Prevalence of Skin Diseases on the Faroe Islands. Copenhagen: GEC GAD; 1963.
Hellgren L: Association between rheumatoid arthritis and psoriasis in total populations. Acta Rheumatol Scand 1969, 15:316–326.
van Romunde LK, Valkenburg HA, Swart-Bruinsma W, et al.: Psoriasis and arthritis. I. A population study. Rheumatol Int 1984, 4:55–60.
Shbeeb M, Uramoto KM, Gibson LE, et al.: The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 2000, 27:1247–1250.
Alamanos Y, Papadopoulos NG, Voulgari PV, et al.: Epidemiology of psoriatic arthritis in northwest Greece, 1982–2001. J Rheumatol 2003, 30:2641–2644.
Trontzas P, Andrianakos A, Miyakis S, et al.: Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheum 2005, 24:583–589.
Madland TM, Apalset EM, Johannessen AE, et al.: Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005, 32:1918–1922.
Gelfand JM, Gladman DD, Mease PJ, et al.: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005, 53:573.
Kaipiainen-Seppanen O: Incidence of psoriatic arthritis in Finland. Br J Rheumatol 1996, 35:1289–1291.
Mallbris L, Larsson P, Bergqvist S, et al.: Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 2005, 124:499–504.
Solinger AM, Hess EV: Rheumatic diseases and AIDS—is the association real? J Rheumatol 1993, 20:678–683.
Espinoza LR, Jara LJ, Espinoza CG, et al.: There is an association between human immunodeficiency virus infection and spondyloarthropathies. Rheum Dis Clin North Am 1992, 18:257–266.
Njobvu P, McGill P, Kerr H, et al.: Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998, 25:1553–1559.
Njobvu P, McGill P: Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 2000, 27:1699–1702.
Mijiyawa M, Oniankitan O, Khan MA: Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000, 12:281–286.
Lopez-Larrea C, Njobvu PD, Gonzalez S, et al.: The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. Arthritis Rheum 2005, 52:275–279.
Scarpa R, Oriente P, Pucino A, et al.: Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984, 23:246–250.
Jones SM, Armas JB, Cohen MG, et al.: Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994, 33:834–839.
Rahman P, Schentag CT, Gladman DD: Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis. Arthritis Rheum 1999, 42:822–823.
Thumboo J, Uramoto K, Shbeeb MI, et al.: Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol 2002, 29:757–762.
Zachariae H, Zachariae R, Blomqvist K, et al.: Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002, 82:108–113.
Borman P, Toy GG, Babaoglu S, et al.: A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol 2007, 26:330–334.
Gelfand JM, Feldman SR, Stern RS, et al.: Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004, 51:704–708.
Sokoll KB, Helliwell PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001, 28:1842–1846.
Wong K, Gladman DD, Husted J, et al.: Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997, 40:1868–1872.
Gladman DD, Farewell VT, Wong K, Husted J: Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998, 41:1103–1110.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Setty, A.R., Choi, H.K. Psoriatic arthritis epidemiology. Curr Rheumatol Rep 9, 449–454 (2007). https://doi.org/10.1007/s11926-007-0073-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-007-0073-3